Furthermore, to assess the discriminatory power of serum p-ERK1/2 levels, we measured to compare p-ERK1/2 and CA19-9 levels in sera of PaCa patients and age-matched benign controls including PT patients. Here, MAPK3 is linked to permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.